Traductor

05 October 2010

Shares in Celldex surge following release of positive trial data on CDX-110

Shares of Celldex Therapeutics surged as much as 20 percent Tuesday after the Journal of Clinical Oncology published positive data from clinical trials of the company's experimental cancer vaccine, CDX-110.

Reference Articles
Celldex reports strong clinical results for cancer vaccine - (FOX Business)
Celldex Therapeutics rises on positive data (VIDEO) - (Forbes)
Celldex rallies on cancer drug data - (MarketWatch)
Celldex Therapeutics soars on data - (TheStreet.com)
Celldex surges on brain cancer drug study data - (Yahoo!Finance)

**Published in "First Word"

No comments:

Post a Comment

CONTACTO · Aviso Legal · Política de Privacidad · Política de Cookies

Copyright © Noticia de Salud